Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,596 | -1,843 | -1,305 | 29 | -2,408 |
| Depreciation Amortization | 20 | 17 | 14 | 8 | 25 |
| Accounts receivable | -8 | -336 | -103 | -1,153 | 2,361 |
| Other Working Capital | 2,310 | 1,041 | 929 | -313 | 359 |
| Other Operating Activity | 82 | 412 | 187 | 1,116 | -1,914 |
| Operating Cash Flow | $-1,191 | $-709 | $-279 | $-313 | $-1,577 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 29 | 29 | -14 | -14 | -13 |
| Other Investing Activity | -2 | -2 | 42 | 42 | -15 |
| Investing Cash Flow | $27 | $27 | $27 | $27 | $-28 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200 | 200 | 50 | 50 | 400 |
| Common Stock Issued | 536 | 10 | 10 | 10 | 505 |
| Other Financing Activity | -100 | -50 | -50 | 0 | 350 |
| Financing Cash Flow | $636 | $160 | $10 | $60 | $1,255 |
| Beginning Cash Position | 557 | 557 | 557 | 557 | 908 |
| End Cash Position | 29 | 35 | 316 | 331 | 557 |
| Net Cash Flow | $-529 | $-522 | $-242 | $-226 | $-351 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,191 | -709 | -279 | -313 | -1,577 |
| Capital Expenditure | -15 | -15 | -14 | -14 | -13 |
| Free Cash Flow | -1,206 | -724 | -293 | -327 | -1,590 |